Post by
Yajne on Mar 29, 2023 9:34pm
Has FDA moved the goalposts?
...can they even do that after a trial is underway and so far advanced? If so, do some folks still not take seriously the broad reach of big Pharma? If so, you are ostriches, go bury your head back in the sand!
Let's hope that somebody within FDA actually cares for the patient, rather than their own "off the record compensation". If TLT's Ph2 results don't speak for themselves and are somehow derailed by some sort of 'new rules' that didn't exist when the trial started, then I've kinda lost faith in mankind, or at least those in powerful positions. C'mon FDA, do the right thing here, many peoples lives depend on it!
Comment by
ScienceFirst on Mar 29, 2023 10:07pm
No plot theories here. Thus changes nothing to the Ph. 2 trial. Nothing.
Comment by
ScienceFirst on Mar 29, 2023 10:09pm
No plot theories here. This changes nothing to the Ph. 2 trial. Nothing.
Comment by
Yajne on Mar 29, 2023 10:49pm
Okay smart guy. And you know that nothing changes to Ph2 trial because you've discussed it with the FDA, or is it just becuase you're such a smart guy? FYI you're now on the record for saying what you just posted.
Comment by
Lesalpes29 on Mar 30, 2023 9:03am
Good post again Steven. It's easy to turn negatively every move or possible move by the FDA. The results so far are good enough for BTD shortly followed by the AA with more results to come. I keep my focus on this and wait for good NR to add some shares! GL
Comment by
StevenBirch on Mar 30, 2023 10:26am
Thanks Lesalpes and I would add, without any knowledge, it looks like PP activity and that's not the end of the world. The bid at $0.26 is growing so that doesn't look like something negative is going on.
Comment by
Rumpl3StiltSkin on Mar 29, 2023 11:22pm
I think if the drug/compound shows obvious efficacy in the lab during preclinical phase then Single arm will be pursued. Just IMO. I think the FDA is trying to stop FT and BTD to the degree that they are. I think very few actually have what it takes to make it to AA or final approval.